Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Oncology"
DOI: 10.1159/000502095
Abstract: Background/Aim: Lenvatinib (LEN) has been developed for the treatment of unresectable hepatocellular carcinoma (u-HCC). We aimed to elucidate the relative change in hepatic reserve function early following LEN treatment in affected patients. Materials/Methods: From March… read more here.
Keywords: hepatocellular carcinoma; change hepatic; hepatic function; unresectable hepatocellular ... See more keywords